Astera Labs (ALAB) financials
Astera Labs reported revenue of $1.6B over the twelve months to Sep 30, 2026 (+153.7% year on year, latest quarter), with a 72.3% gross margin and a 30.6% operating margin in its latest quarter. Read from its own SEC filings (XBRL), each period with the filing behind it.
Quarters, as filed
| Quarter ended | Revenue | Gross profit | Operating income | Net income | Filed |
|---|---|---|---|---|---|
| Sep 30, 2026 | $584.9M | $422.8M | $179.1M | $182.9M | Nov 4, 2026 |
| Jun 30, 2026 | $392.4M | $287.6M | $89.2M | $153.1M | Aug 5, 2026 |
| Mar 31, 2026 | $308.4M | $235.1M | $61.8M | $80.3M | May 6, 2026 |
| Dec 31, 2025 | $270.6M | $204.5M | $67.0M | $45.0M | Feb 20, 2026 |
| Sep 30, 2025 | $230.6M | $175.8M | $55.4M | $91.1M | Nov 4, 2026 |
| Jun 30, 2025 | $191.9M | $145.6M | $39.8M | $51.2M | Aug 5, 2026 |
| Mar 31, 2025 | $159.4M | $119.4M | $11.3M | $31.8M | May 6, 2026 |
| Dec 31, 2024 | $141.1M | $104.4M | $144,000.00 | $24.7M | Feb 20, 2026 |
What Astera Labs expects
In its earnings release of Nov 3, 2026 (Form 8-K), Astera Labs gave the following guidance, in its own words, not a forecast of ours and not analysts' consensus.
| Period | Measure | Guidance |
|---|---|---|
| Fourth Quarter of Fiscal 2026 | Revenue | $730.0M to $750.0M |
| Fourth Quarter of Fiscal 2026 | Gross margin (GAAP) | 72.0% |
| Fourth Quarter of Fiscal 2026 | Diluted EPS (GAAP) | $1.13 to $1.17 |
| Fourth Quarter of Fiscal 2026 | Gross margin (non-GAAP) | 72.0% |
| Fourth Quarter of Fiscal 2026 | Diluted EPS (non-GAAP) | $1.62 to $1.66 |
For the Third Quarter of Fiscal 2026, Astera Labs reported revenue of $584.9M, 6.3% above the midpoint of the guidance it gave on Aug 4, 2026 ($540.0M to $560.0M): above the range.
| Period | Measure | Guided | As filed | Gap to midpoint |
|---|---|---|---|---|
| Third Quarter of Fiscal 2026 | Revenue | $540.0M to $560.0M | $584.9M | +6.3% (above the range) |
| Third Quarter of Fiscal 2026 | Gross margin (GAAP) | 72.0% | 72.3% | +0.3 points (within the range) |
| Third Quarter of Fiscal 2026 | Diluted EPS (GAAP) | $0.87 to $0.92 | $0.99 | +$0.09 (above the range) |
| Second Quarter of Fiscal 2026 | Revenue | $355.0M to $365.0M | $392.4M | +9.0% (above the range) |
| Second Quarter of Fiscal 2026 | Gross margin (GAAP) | 73.0% | 73.3% | +0.3 points (within the range) |
| Second Quarter of Fiscal 2026 | Diluted EPS (GAAP) | $0.44 to $0.46 | $0.83 | +$0.38 (above the range) |
The last guidance the company gave for each period, and what it then filed. Gross margin and EPS on a GAAP basis only: non-GAAP adjustments are not filed.
Astera Labs's next results are expected around Feb 9, 2027: an estimate from the release of the same quarter last year (Feb 10, 2026), plus 52 weeks, not a date the company announced.
Where Astera Labs' revenue comes from
Revenue by region, the quarter ended Sep 30, 2026: Singapore $310.2M (53%), China $146.7M (25%), Taiwan $87.0M (15%), United States $6.0M (1%) and Other $35.0M (6%), for $584.9M in all. 10-Q filed Nov 4, 2026
Revenue by product, the fiscal year ended Dec 31, 2025: Product $852.5M (100%) and Technology Service $0.00 (0%), for $852.5M in all. 10-K filed Feb 20, 2026
Customers Astera Labs discloses, the quarter ended Sep 30, 2026: Customer A 53.0% of revenue (not named by the company), Customer B 14.0% of revenue (not named by the company) and Customer C 10.0% of revenue (not named by the company). 10-Q filed Nov 4, 2026
- Astera Labs revenue by quarter
- Astera Labs gross profit by quarter
- Astera Labs operating income by quarter
- Astera Labs net income by quarter